Financial statements Centrum Badań Mikrobiologicznych Imienia Dr Jana Bobra
Balance sheet data of CENTRUM BADAŃ MIKROBIOLOGICZNYCH IMIENIA DR JANA BOBRA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 523 450,78 | 754 769,42 | 767 709,05 | 770 604,64 | 689 186,92 | 925 442,15 |
| A. Fixed assets | 166 435,89 | 114 286,49 | 59 832,63 | 75 585,69 | 77 127,70 | 95 482,15 |
| B. Current assets | 357 014,89 | 640 482,93 | 707 876,42 | 695 018,95 | 612 059,22 | 829 960,00 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 523 450,78 | 754 769,42 | 767 709,05 | 770 604,64 | 689 186,92 | 925 442,15 |
| A. Equity | 341 068,90 | 616 255,35 | 327 082,77 | 462 006,22 | 340 738,29 | 653 192,59 |
| B. Liabilities and provisions for liabilities | 182 381,88 | 138 514,07 | 440 626,28 | 308 598,42 | 348 448,63 | 272 249,56 |
| I. Long-term liabilities | - | - | - | 18 216,69 | 0,00 | - |
| II. Short-term liabilities | 158 428,33 | 120 498,28 | 440 626,28 | 290 381,73 | 304 381,78 | 229 033,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.